Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;3(1):31-42.
doi: 10.1177/1756283X09354136.

Immunomodulators for all patients with inflammatory bowel disease?

Sandro Ardizzone  1 , Andrea Cassinotti, Gianpiero Manes, Gabriele Bianchi Porro
Affiliations

Immunomodulators for all patients with inflammatory bowel disease?

Sandro Ardizzone et al. Therap Adv Gastroenterol. 2010 Jan.

Abstract

Recent insight into the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC) have led to the development of new treatment options, with a progressive shift to more evidence-based strategies based on sound pathophysiological rationales. A better understanding of inflammatory bowel disease (IBD) pathophysiology has progressively resulted in a more frequent use of immunomodulators. We review the recommended or suggested use of conventional immunomodulators such as azathioprine, 6-mercaptopurine, methotrexate in the treatment of IBD. Moreover, an effort is made to explore some critical areas in which early and more diffuse use of these agents may be advocated.

Keywords: Crohn’s disease; azathioprine; immunomodulators; inflammatory bowel disease (IBD); treatment; ulcerative colitis.

PubMed Disclaimer

References

    1. Alfadhli A.A.F., McDonald J.W.D., Feagan B.G. (2004) Methotrexate for induction of remission in refractory Crohn’s disease. Cochrane Database of Systematic Reviews 4: CD003459. DOI: 10.1002/14651858.CD003459.pub2 - PubMed
    1. Ardizzone S., Bianchi Porro G. (2002) Inflammatory bowel disease: new insights into pathogenesis and therapy. J Intern Med 252: 475–496 - PubMed
    1. Ardizzone S., Bollani S., Manzionna G., Imbesi V., Colombo E., Bianchi Porro G. (2003) Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn’s disease: a randomized, investigator-blind study. Dig Liver Dis 35: 619–627 - PubMed
    1. Ardizzone S., Maconi G., Russo A., Imbesi V., Colombo E., Bianchi Porro G. (2006) Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 55: 47–53 - PMC - PubMed
    1. Ardizzone S., Maconi G., Sampietro G.M., Russo A., Radice E., Colombo E., et al. (2004) Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology 127: 730–740 - PubMed

LinkOut - more resources